Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -1.56M | -1.24M | -2.14M | -883.82K | -1.77M | -1.18M | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K | -1.7M | -23.51M | -1.46M | -538.87K | -1.24M | 667.12K | -4.04M | -2.88M | -6.19M |
Depreciation & Amortization | 77.97K | 76.86K | 98.58K | 96.16K | 72.53K | 64.79K | 65.4K | 64.63K | 50.88K | 42.62K | 42.35K | 37.2K | 34.88K | 34.71K | 18.98K | 789 | 2.29K | 3.11K | 3.18K | 3.18K | 3.19K | 3.18K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 81.95K | 35.25K | 199.16K | 216.12K | 48.15K | 2M | 603.78K | -467.21K | -612.81K | 913.88K | -1.04M | -137.83K | 172.7K | 322.92K | 21.17K | -9.93K | -57.29K | -33.33K | 9.56K | 1.51K | 19.37K |
Other Non-Cash Items | -336.99K | n/a | 142.05K | 571.93K | 1.06M | n/a | -2.25M | 4.38K | -2.55M | 12K | 377 | 1.08M | -1.08M | n/a | 18.33M | 65 | -10.88K | 9 | -903.7K | 3.5M | 2.33M | 5.78M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 905.09K | -905.09K | 284.3K | -512.07K | -636.94K | -580.02K | 937.57K | -227.79K | -1.59M | -1.96M | -1.48M | -926.8K | -1.83M | -182.39K | 2.92M | 332.43K | -26.34K | -71.09K | -78.72K | -60.67K | -69.38K | 99.97K |
Operating Cash Flow | -917.98K | -2.07M | -1.62M | -727.8K | -1.27M | -1.7M | -3.41M | -1.36M | -4.58M | -3.19M | -2.69M | -457.29K | -3.78M | -1.85M | -2.25M | -1.12M | -573.8K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |
Capital Expenditures | 5.13K | -5.13K | 770.24K | -34.14K | -550.19K | -212.02K | -439.3K | -609.52K | -572.22K | -699.8K | 382.37K | -11.79K | -294.23K | -178.4K | -193.98K | 1.12M | 573.8K | -2 | 3 | -2 | 2 | -5 |
Cash Acquisitions | n/a | n/a | -10.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 34.45K | n/a | n/a | -1.14K | -14.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -109.64K | n/a | -215.49K | -110.26K | -331.78K | -204.53K | -87.4K | -153.59K | 432.31K | -605.8K | n/a | 28.49K | 34.75K | 33.23K | -1.14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -5.12K | -104.52K | -50.21K | -118.3K | -491.78K | -212.02K | -531.54K | -670.6K | -542.21K | -668.74K | -269.23K | 18.86K | -259.48K | -146.3K | -14.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | -58.38K | -17.16K | 435.79K | -29.66K | -28.58K | -29.61K | n/a | -29.26K | -32.39K | -31.48K | -2.1M | -43.46M | 29.02M | -1.9M | -23.66K | 1.28M | 550.65K | 1.1M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.14M | n/a | -34.32K | n/a | -506.82K | n/a | n/a | n/a | -99K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.8M | n/a | n/a | 75.54K | n/a | 17.16K | n/a | 87.85K | n/a | 45K | -32.87K | n/a | 1.16K | n/a | 13.19M | -99K | 99K | 99K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 7.8M | n/a | 724.5K | 75.54K | 3.61M | 355.3K | 2.05M | 1.95M | -28.58K | 5.4M | -30.52K | -63.57K | 4.06M | -538.3K | -2.1M | n/a | 29.12M | 12.44M | -23.66K | 1.28M | 550.65K | 1.1M |
Net Cash Flow | 6.84M | -2.21M | -183.13K | -998.88K | 2.18M | -1.56M | -2.52M | 698.91K | -5.93M | 1.14M | -2.55M | -883.35K | 435.27K | -2.53M | -18.73M | -1.17M | 28.55M | 11.13M | -341.44K | 651.51K | -61.5K | 806.71K |
Free Cash Flow | -912.85K | -2.08M | -845.76K | -761.94K | -1.82M | -1.91M | -3.85M | -1.97M | -5.15M | -3.88M | -2.31M | -469.08K | -4.07M | -2.03M | -2.44M | -1.12M | -573.8K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |
Adj. Free Cash Flow | -912.85K | -2.08M | -845.76K | -761.94K | -1.82M | -1.91M | -3.85M | -1.97M | -5.15M | -3.88M | -2.31M | -469.08K | -4.07M | -2.03M | -2.44M | -1.12M | -573.8K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |
Maintenance CapEx | -5.13K | -5.13K | 770.24K | n/a | -544.78K | -143.35K | -320.45K | -455.75K | -339.94K | -535.5K | 709.65K | n/a | n/a | n/a | n/a | 1.15M | 603.32K | n/a | 6 | n/a | 4 | n/a |
Growth CapEx | 10.26K | n/a | n/a | -34.14K | -5.41K | -68.67K | -118.85K | -153.78K | -232.28K | -164.3K | -327.28K | -11.79K | -294.23K | -178.4K | -193.98K | -24.97K | -29.51K | -2 | -3 | -2 | -2 | -5 |
Owner Earnings | -923.11K | -2.08M | -845.76K | -727.8K | -1.82M | -1.84M | -3.73M | -1.81M | -4.92M | -3.72M | -1.98M | -457.29K | -3.78M | -1.85M | -2.25M | 24.97K | 29.51K | -1.3M | -312.11K | -600.81K | -618.85K | -297.36K |
Add to Watchlist
Select watchlists to add or remove SBFM